Julia Kanterman

1.3k total citations
9 papers, 1.1k citations indexed

About

Julia Kanterman is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Julia Kanterman has authored 9 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Julia Kanterman's work include Immune cells in cancer (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immune Cell Function and Interaction (3 papers). Julia Kanterman is often cited by papers focused on Immune cells in cancer (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immune Cell Function and Interaction (3 papers). Julia Kanterman collaborates with scholars based in Israel, Germany and Greece. Julia Kanterman's co-authors include Michal Baniyash, Moshe Sade-Feldman, Eliran Ish‐Shalom, Mazal Elnekave, E. Philip Horwitz, Yaron Meirow, Ayala Hubert, Olga Mizrahi, Yair Klieger and Michal Lotem and has published in prestigious journals such as Immunity, The Journal of Immunology and Cancer Research.

In The Last Decade

Julia Kanterman

9 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Kanterman Israel 9 739 517 299 77 60 9 1.1k
Moshe Sade-Feldman United States 15 784 1.1× 536 1.0× 362 1.2× 103 1.3× 72 1.2× 32 1.3k
Hélène Berger France 11 621 0.8× 341 0.7× 420 1.4× 92 1.2× 85 1.4× 11 1.1k
Kyuho Kang South Korea 16 554 0.7× 262 0.5× 463 1.5× 153 2.0× 54 0.9× 36 1.1k
Hokuto Kamon Japan 6 609 0.8× 306 0.6× 205 0.7× 88 1.1× 35 0.6× 6 1.1k
Guo‐Yun Chen United States 11 680 0.9× 151 0.3× 434 1.5× 47 0.6× 66 1.1× 25 1.1k
Jihang Ju United States 15 333 0.5× 172 0.3× 333 1.1× 108 1.4× 105 1.8× 20 824
Hye‐Jwa Oh South Korea 18 674 0.9× 256 0.5× 345 1.2× 95 1.2× 27 0.5× 26 1.2k
Beatriz Martins Tavares‐Murta Brazil 16 454 0.6× 257 0.5× 201 0.7× 86 1.1× 50 0.8× 41 948
Vida Hashemi Iran 13 363 0.5× 260 0.5× 254 0.8× 115 1.5× 59 1.0× 20 839
Bradley N. Martin United States 12 456 0.6× 113 0.2× 424 1.4× 101 1.3× 37 0.6× 17 906

Countries citing papers authored by Julia Kanterman

Since Specialization
Citations

This map shows the geographic impact of Julia Kanterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Kanterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Kanterman more than expected).

Fields of papers citing papers by Julia Kanterman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Kanterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Kanterman. The network helps show where Julia Kanterman may publish in the future.

Co-authorship network of co-authors of Julia Kanterman

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Kanterman. A scholar is included among the top collaborators of Julia Kanterman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Kanterman. Julia Kanterman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Tarcic, Ohad, Ioannis S. Pateras, Tomer Cooks, et al.. (2016). RNF20 Links Histone H2B Ubiquitylation with Inflammation and Inflammation-Associated Cancer. Cell Reports. 14(6). 1462–1476. 103 indexed citations
2.
Sade-Feldman, Moshe, Julia Kanterman, Yair Klieger, et al.. (2016). Clinical Significance of Circulating CD33+CD11b+HLA-DR− Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab. Clinical Cancer Research. 22(23). 5661–5672. 171 indexed citations
3.
Meirow, Yaron, Julia Kanterman, & Michal Baniyash. (2015). Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the Fate. Frontiers in Immunology. 6. 523–523. 67 indexed citations
4.
Ish‐Shalom, Eliran, Yaron Meirow, Moshe Sade-Feldman, et al.. (2015). Impaired SNX9 Expression in Immune Cells during Chronic Inflammation: Prognostic and Diagnostic Implications. The Journal of Immunology. 196(1). 156–167. 18 indexed citations
5.
Kanterman, Julia, Moshe Sade-Feldman, Moshe Biton, et al.. (2014). Adverse Immunoregulatory Effects of 5FU and CPT11 Chemotherapy on Myeloid-Derived Suppressor Cells and Colorectal Cancer Outcomes. Cancer Research. 74(21). 6022–6035. 139 indexed citations
6.
Baniyash, Michal, Moshe Sade-Feldman, & Julia Kanterman. (2013). Chronic inflammation and cancer: suppressing the suppressors. Cancer Immunology Immunotherapy. 63(1). 11–20. 89 indexed citations
7.
Sade-Feldman, Moshe, Julia Kanterman, Eliran Ish‐Shalom, et al.. (2013). Tumor Necrosis Factor-α Blocks Differentiation and Enhances Suppressive Activity of Immature Myeloid Cells during Chronic Inflammation. Immunity. 38(3). 541–554. 262 indexed citations
8.
Kanterman, Julia, Moshe Sade-Feldman, & Michal Baniyash. (2012). New insights into chronic inflammation-induced immunosuppression. Seminars in Cancer Biology. 22(4). 307–318. 183 indexed citations
9.
Sevko, Alexandra, Moshe Sade-Feldman, Julia Kanterman, et al.. (2012). Cyclophosphamide Promotes Chronic Inflammation–Dependent Immunosuppression and Prevents Antitumor Response in Melanoma. Journal of Investigative Dermatology. 133(6). 1610–1619. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026